A Phase II Pilot Study of Glivec (imatinib mesylate formerly known as STI571) Combined with Induction Chemotherapy in Blast-Phase Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia, to evaluate safety and improve remission rate.(CMLALL01)
收藏Research Data Australia2024-08-03 收录
下载链接：
https://researchdata.edu.au/a-phase-ii-remission-ratecmlall01/2538246
下载链接
链接失效反馈官方服务：
资源简介：
Dataset includes Data for 41 patients with blast phase CML, utilising Glivec and monitoring remission status Demographic data, diagnostic data, treatment data, outcome data
提供机构：
Health Data Australia Contributor Records
